Location History:
- Swampscott, MA (US) (2009)
- Collegeville, PA (US) (2010)
Company Filing History:
Years Active: 2009-2010
Title: Michael E Burczynski: Innovator in Drug Monitoring and Cancer Diagnosis
Introduction
Michael E Burczynski is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the fields of drug monitoring and cancer diagnosis through his innovative patents. With a total of 2 patents, Burczynski's work has the potential to impact medical practices and improve patient outcomes.
Latest Patents
Burczynski's latest patents include "Methods for monitoring drug activities in vivo" and "Methods for diagnosing RCC and other solid tumors." The first patent focuses on methods, systems, and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. This invention identifies numerous drug activity genes that can be modulated by CCI-779 or other drugs, allowing these genes to serve as surrogate markers for detecting or monitoring drug activities in vivo. The second patent addresses methods, systems, and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies disease genes that are differentially expressed in the peripheral blood of patients with RCC or other solid tumors compared to disease-free individuals, enabling the use of these genes as surrogate markers for diagnosis.
Career Highlights
Michael E Burczynski is associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on innovative solutions that address critical health issues. His contributions have been recognized within the industry, showcasing his expertise and commitment to advancing medical science.
Collaborations
Burczynski has collaborated with notable colleagues, including Natalie C Twine and William L Trepicchio. These collaborations have likely enhanced the development and implementation of his innovative ideas.
Conclusion
Michael E Burczynski's contributions to drug monitoring and cancer diagnosis through his patents reflect his dedication to improving healthcare. His work continues to pave the way for advancements in medical technology and patient care.